Skip to main content

COVID-19 Topic Center

Diabetes News

News
Patients with diabetes experienced improved medication adherence and glycemic control when they had computer patient portal access combined with mobile patient portal access, according to new study findings. Ilana Graetz, PhD, Rollins School of Public Health, Department of Health Policy and…
News
An intervention involving hemoglobin A1c (HbA1c) testing in black barbershops could help identify undiagnosed diabetes and prediabetes in black men, according to new research published in JAMA Internal Medicine. These findings are encouraging, especially because the prevalence of diabetic…
News
Median blood pressure and glycosylated hemoglobin (A1C) decreased in a homeless population in the months after pharmacist intervention, according to a study published online in the Journal of the American Pharmacists Association.  “Homeless patients with hypertension and/or type 2 diabetes who had…
News
Researchers recently found that there is substantial underreporting regarding adverse drug events (ADEs) that became worse among patients taking apixaban and empagliflozin. In order to better understand reporting rates of ADEs with apixaban and empagliflozin as reports move up to the next level of…
News
Macleods Pharma USA Inc is recalling nearly 32,000 bottles of pioglitazone hydrochloride tablets because of superpotency concerns. The recall was included in the October 23, 2019, US Food and Drug Administration (FDA) Enforcement Report.  The recall affects 30-count bottles of pioglitazone…
News
(Reuters) - AstraZeneca Plc said on Tuesday that the U.S. Food and Drug Administration has granted fast track status for the development of its diabetes drug Farxiga to prevent heart and kidney failure in patients with chronic kidney disease (CKD). Farxiga, one of AstraZeneca's top 10 drugs by…
News
Increasing intake of polyunsaturated fatty acids (PUFA) appears to have no effect on the risk of developing diabetes, according to the results of a recent analysis. To determine the effects of omega-3, omega-6, and total PUFA intake on diabetes and glucose metabolism, researchers conducted a…
News
Researchers recently sought to understand how vitamin D3 supplementation impacted diabetes risk among patients at high risk for the disease. According to their findings, published online in the New England Journal of Medicine, they found that supplementation at a dose of 4000 IU per day did not…
News
By Marilynn Larkin NEW YORK (Reuters Health) - The American Diabetes Association (ADA) has updated its Standards of Medical Care in Diabetes to include diabetes technology, with recommendations for self-monitoring of blood glucose, continuous glucose monitors and automated insulin delivery systems…
News
US military veterans who received intensive glucose control therapy for type 2 diabetes over a median 5.6 years had no lower risk of cardiovascular events over 15 years than those who received standard glucose therapy, according to a study published in The New England Journal of Medicine. The…
Back to Top